Metropolis Healthcare Share Price Today (METROPOLIS)
Today’s Metropolis Stock Read
Metropolis Healthcare is trading down 1.78% at ₹543.35. With a market cap of ₹11,298.33 Cr, it trades at a P/E of 59.43. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Metropolis Healthcare is trading down 1.78% at ₹543.35. With a market cap of ₹11,298.33 Cr, it trades at a P/E of 59.43. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Metropolis Healthcare Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Metropolis Healthcare Limited, framed against the sector median so the premium or discount is obvious at a glance.
Metropolis Healthcare Limited trades at a P/E of 59.43× and P/B of 7.47×.
Valuation
Profitability
Growth
Financial Health
Metropolis Healthcare Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Metropolis Healthcare Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Metropolis Healthcare Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Metropolis Healthcare Limited, switchable between annual and quarterly views, consolidated or standalone.
Metropolis Healthcare Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹11,298.33 Cr and reported EPS of ₹9.18.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 761 | 856 | 998 | 1,228 | 1,148 | 1,208 | 1,331 | 1,646 |
| Other Income | 8 | 9 | 12 | 18 | 15 | 9 | 15 | 26 |
| Total Income | 769 | 865 | 1,010 | 1,246 | 1,163 | 1,217 | 1,346 | 1,671 |
| Cost of Goods Sold (COGS) | 174 | 204 | 252 | 276 | 253 | 243 | 269 | 325 |
| Gross Profit | 588 | 652 | 746 | 952 | 895 | 965 | 1,063 | 1,321 |
| +Operating Expenses | 387 | 419 | 460 | 610 | 607 | 683 | 760 | 920 |
| EBITDA | 200 | 233 | 286 | 343 | 288 | 283 | 303 | 401 |
| +Non-Operating Expenses | 19 | 23 | 54 | 99 | 116 | 117 | 127 | 149 |
| Profit Before Tax (PBT) | 187 | 169 | 244 | 293 | 188 | 175 | 191 | 259 |
| +Tax Expense | 63 | 41 | 61 | 79 | 44 | 46 | 45 | 68 |
| Total Profit for Period | 124 | 128 | 183 | 215 | 143 | 128 | 146 | 191 |
| Less: Non-controlling Interests | 3 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Net Profit (Owner's PAT) | 120 | 127 | 183 | 214 | 143 | 128 | 145 | 190 |
| Earnings Per Share (EPS) | 5.99 | 6.29 | 8.95 | 10.46 | 6.98 | 6.24 | 7.00 | 9.17 |
| Diluted Shares Outstanding (Nos.) | 20 | 20 | 20 | 20 | 20 | 20 | 21 | 21 |
| +Additional Disclosures | 760 | 872 | 1,017 | 1,243 | 1,229 | 1,285 | 1,424 | 1,734 |
| Sales Growth % | — | 12.51 | 16.53 | 23.08 | -6.52 | 5.18 | 10.23 | 23.64 |
| YoY Sales Growth % | — | 12.51 | 16.53 | 23.08 | -6.52 | 5.18 | 10.23 | 23.64 |
| Material Cost % | 23 | 24 | 25 | 22 | 22 | 20 | 20 | 20 |
| Employee Cost % | 23 | 22 | 20 | 19 | 22 | 23 | 24 | 23 |
| Other Cost % | 28 | 27 | 26 | 31 | 31 | 34 | 33 | 33 |
| OPM % | 26 | 27 | 29 | 28 | 25 | 23 | 23 | 24 |
| Tax % | 34 | 24 | 25 | 27 | 24 | 26 | 24 | 26 |
| Profit Growth % | — | 5.97 | 43.80 | 16.98 | -33.29 | -10.54 | 13.42 | 31.08 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| +Additional Fields | 180 | 194 | 240 | 280 | 199 | 188 | 194 | 267 |
Metropolis Healthcare segment analysis: revenue and profit mix.
Disclosed business segments at Metropolis Healthcare with their share of revenue and profit, switchable between consolidated and standalone reporting.
Metropolis Healthcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Metropolis Healthcare Limited.
Our AI distills the core fundamental drivers supporting Metropolis Healthcare Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Metropolis Healthcare Limited's investment case rests on 7 positive markers and 7 flagged concerns drawn from the latest reported filings.
What you're getting.
Metropolis Healthcare exhibits robust quarterly sales growth, with a 23.2% increase in the latest quarter, indicating strong demand for its services and a healthy market position within the healthcare sector.
The company boasts a healthy operating profit margin (OPM) of 22.4% and a Return on Equity (ROE) of 11.5%, demonstrating efficient cost management and strong pricing power in its operations.
Despite a relatively high P/E ratio, Metropolis shows a considerable Return on Capital Employed (ROCE) of 14.70%, suggesting effective utilization of its capital and potential for sustained future growth.
Metropolis maintains a very low debt-to-equity ratio of 0.15, signifying a financially stable position with minimal reliance on debt financing, which significantly reduces its financial risk.
The broader healthcare service provider industry offers significant growth potential, driven by increasing health awareness, an aging population, and expanding diagnostic demand across the region.
What can break it.
The company's high Price-to-Earnings (P/E) ratio of 66.20 suggests the stock might be overvalued compared to its earnings, potentially making it vulnerable to market corrections and investor sentiment shifts.
Promoter holding at 48.9% is just below the ideal 50% threshold for complete control, which could potentially raise concerns about future corporate governance and strategic decision-making.
Recent stock price volatility, with significant swings between a 52-week high of 2263 and a low of 1315, indicates market uncertainty and potential investment risk for shareholders.
Although quarterly profits show growth (18.7% increase), the absolute profit after tax of 45.1 Cr is relatively modest compared to its 10062 Cr market capitalization.
The diagnostic sector is highly competitive, with peers like Dr Lal Pathlabs exhibiting higher ROCE (28.88%) and lower P/E (50.52), potentially pressuring Metropolis's margins and market position.
What would change my mind.
Trim if P/E re-rates above 77. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Metropolis Healthcare Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Metropolis Healthcare Limited is highlighted for quick read-across.
Quick Compare
Metropolis Healthcare Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Metropolis Healthcare Limited — derived from the live tape, not yesterday's close.
Metropolis Healthcare Limited last traded at ₹543.35 with an intraday range of ₹540.65–₹563.5 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹543.35| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 603.38 | +60.03 | +11.05% |
| R3 | 580.53 | +37.18 | +6.84% |
| R2 | 572.02 | +28.67 | +5.28% |
| R1 | 557.68 | +14.33 | +2.64% |
| PIVOT | 549.17 | 5.82 | 1.07% |
| CURRENT | 543.35 | — | — |
| S1 | 489.13 | -54.22 | -9.98% |
| S2 | 511.98 | -31.37 | -5.77% |
| S3 | 526.32 | -17.03 | -3.13% |
| S4 | 534.83 | -8.52 | -1.57% |
METROPOLIS is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 555.2 ~ 563.5
Trading Inside opening range
Metropolis Healthcare Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Metropolis Healthcare Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Metropolis Healthcare Limited stood at 42.5% of traded volume, against a 20-day average of 51.0%.
Metropolis Healthcare announcements: results, concalls, ratings, M&A.
Filings Metropolis Healthcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Metropolis Healthcare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 138 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Metropolis Healthcare Limited has informed the Exchange about Link of Recording
Copy of Newspaper Publication
Metropolis Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Updates
Metropolis Healthcare Limited has informed the Exchange regarding 'General Update'.
Options to purchase securities
Metropolis Healthcare Limited has informed the Exchange about Grant of Stock Benefits
ESOP/ESOS/ESPS
Metropolis Healthcare Limited has informed the Exchange regarding Allotment of 4,200 Equity Shares under the Metropolis-Restrictive Stock Unit Plan,…
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Metropolis Healthcare insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Metropolis Healthcare as reported to SEBI — buying and selling signals from the people who know the business best.
Metropolis Healthcare insider activity below tracks 4 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Sushil Shah Family Trust | Insider | 29 May 2025 | buy | +11.67 L | — | — |
| Sushil Kanubhai Shah | Insider | 29 May 2025 | sell | −11.67 L | — | — |
| Duru Shah Family Trust | Insider | 26 Mar 2025 | buy | +7.66 L | — | — |
| Dr. Duru Sushil Shah | Insider | 26 Mar 2025 | sell | −7.66 L | — | — |
Metropolis Healthcare dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Metropolis Healthcare has declared, sequenced by announce and record date.
Metropolis Healthcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Metropolis Healthcare Limited: business, sector, key facts.
What Metropolis Healthcare Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Metropolis Healthcare Limited operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: METROPOLIS, BSE: 542650.
Metropolis Healthcare Limited is a leading provider of diagnostic services in India and internationally. Their core business revolves around offering a comprehensive range of clinical laboratory testing and profiling services to individuals and corporate clients. This includes a wide array of tests designed for various medical specialties and purposes.
The company's services cater to a broad spectrum of medical needs. They provide diagnostic services specializing in oncology (cancer), neurology (nervous system), gynecology (women's health), and nephrology (kidney disease). This specialized focus allows them to offer highly targeted and accurate testing for a variety of health conditions.
Beyond specialized testing, Metropolis also offers a comprehensive suite of health check-up packages. These packages are tailored to different demographic groups, including men, women, senior citizens, youth, and corporate employees. This approach allows for preventative health measures and early detection of potential health problems.
The diagnostic services provided by Metropolis play a crucial role in various stages of healthcare. Their tests are used for disease prediction, early detection through screening, confirming diagnoses, and monitoring the progression of existing conditions. This comprehensive approach contributes significantly to effective healthcare management.
In addition to their core diagnostic services, Metropolis also offers corporate wellness programs. These programs are designed to improve the health and well-being of employees within organizations. They also provide laboratory information system services and support clinical research initiatives, further expanding their reach within the healthcare ecosystem.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Health X Platform (HEALTHX) Share PricePeer
- Krsnaa Diagnostics (KRSNAA) Share PricePeer
- Dr Lal Path Labs (LALPATHLAB) Share PricePeer
- Suraksha Diagnostic (SURAKSHA) Share PricePeer
- Thyrocare Technologies (THYROCARE) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Metropolis Healthcare Limited (METROPOLIS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Metropolis Healthcare Limited (METROPOLIS)?
The current share price of Metropolis Healthcare Limited (METROPOLIS) is ₹543.35. Today, the stock has declined by ₹9.85 (1.78%), trading in a range of ₹540.65 to ₹563.5. The stock opened at ₹557.9 with a trading volume of 1,98,719 shares.
02Is Metropolis Healthcare Limited stock a good investment for long-term?
Metropolis Healthcare Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹11,298.33 crores, P/E ratio of 59.43, ROE of 13.37%, and ROCE of 14.70%. The dividend yield stands at 0.37%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Metropolis Healthcare Limited stock?
The 52-week high price of Metropolis Healthcare Limited (METROPOLIS) is ₹2,263, while the 52-week low is ₹412.25. Currently trading at ₹543.35, the stock is 7.1% away from its 52-week low and 76.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Metropolis Healthcare Limited stock at the current price?
Whether to buy Metropolis Healthcare Limited stock at ₹543.35 depends on multiple factors. The stock is currently trading with a P/E ratio of 59.43 and P/B ratio of 7.47. Today's performance shows a loss of 1.78%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Metropolis Healthcare Limited and when is the next dividend?
Metropolis Healthcare Limited offers a dividend yield of 0.37%, which means for every ₹100 invested at the current price of ₹543.35, you can expect to receive approximately ₹0.37 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Metropolis Healthcare Limited?
Metropolis Healthcare Limited's key financial metrics include: P/E Ratio: 59.43, P/B Ratio: 7.47, ROE: 13.37%, ROCE: 14.70%, Dividend Yield: 0.37%, EPS: ₹9.18, Book Value: ₹73.13, and Debt-to-Equity: 0.15. The company's market cap stands at ₹11,298.33 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Metropolis Healthcare Limited stock performing today in the market?
Metropolis Healthcare Limited stock opened at ₹557.9 and is currently trading at ₹543.35, showing a decline of ₹9.85 (1.78%). The intraday high is ₹563.5 and low is ₹540.65. The trading volume stands at 1,98,719 shares, indicating moderate market participation today.
08What is the P/E ratio of Metropolis Healthcare Limited and what does it indicate?
Metropolis Healthcare Limited has a Price-to-Earnings (P/E) ratio of 59.43, which means investors are willing to pay ₹59.43 for every ₹1 of earnings. With an EPS of ₹9.18, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Metropolis Healthcare Limited (METROPOLIS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.